1 Dermatological Drugs Market Overview

• 1.1 Dermatological Drugs Product Overview
• 1.2 Dermatological Drugs Market Segment by Type
• 1.2.1 Prescription-Based Drugs

1.2.2 Over-the-Counter Drugs

1.3 Global Dermatological Drugs Market Size by Type

1.3.1 Global Dermatological Drugs Sales and Growth by Type

1.3.2 Global Dermatological Drugs Sales and Market Share by Type (2013-2018)

1.3.3 Global Dermatological Drugs Revenue and Market Share by Type (2013-2018)

1.3.4 Global Dermatological Drugs Price by Type (2013-2018)

2 Global Dermatological Drugs Market Competition by Company

• 2.1 Global Dermatological Drugs Sales and Market Share by Company (2013-2018)
• 2.2 Global Dermatological Drugs Revenue and Share by Company (2013-2018)
• 2.3 Global Dermatological Drugs Price by Company (2013-2018)
• 2.4 Global Top Players Dermatological Drugs Manufacturing Base Distribution, Sales Area, Product Types
• 2.5 Dermatological Drugs Market Competitive Situation and Trends
• 2.5.1 Dermatological Drugs Market Concentration Rate

2.5.2 Global Dermatological Drugs Market Share of Top 5 and Top 10 Players

2.5.3 Mergers & Acquisitions, Expansion

3 Dermatological Drugs Company Profiles and Sales Data

• 3.1 Bayer
• 3.1.1 Company Basic Information, Manufacturing Base and Competitors

3.1.2 Dermatological Drugs Product Category, Application and Specification

3.1.3 Bayer Dermatological Drugs Sales, Revenue, Price and Gross Margin(2013-2018)

3.1.4 Main Business Overview

3.2 Johnson & Johnson

3.2.1 Company Basic Information, Manufacturing Base and Competitors

3.2.2 Dermatological Drugs Product Category, Application and Specification

3.2.3 Johnson & Johnson Dermatological Drugs Sales, Revenue, Price and Gross Margin(2013-2018)

3.2.4 Main Business Overview

3.3 Pfizer

3.3.1 Company Basic Information, Manufacturing Base and Competitors

3.3.2 Dermatological Drugs Product Category, Application and Specification

3.3.3 Pfizer Dermatological Drugs Sales, Revenue, Price and Gross Margin(2013-2018)

3.3.4 Main Business Overview

3.4 Novartis

3.4.1 Company Basic Information, Manufacturing Base and Competitors

3.4.2 Dermatological Drugs Product Category, Application and Specification

3.4.3 Novartis Dermatological Drugs Sales, Revenue, Price and Gross Margin(2013-2018)

3.4.4 Main Business Overview

3.5 GlaxoSmithKline

3.5.1 Company Basic Information, Manufacturing Base and Competitors

3.5.2 Dermatological Drugs Product Category, Application and Specification

3.5.3 GlaxoSmithKline Dermatological Drugs Sales, Revenue, Price and Gross Margin(2013-2018)

3.5.4 Main Business Overview

3.6 AstraZeneca

3.6.1 Company Basic Information, Manufacturing Base and Competitors

3.6.2 Dermatological Drugs Product Category, Application and Specification

3.6.3 AstraZeneca Dermatological Drugs Sales, Revenue, Price and Gross Margin(2013-2018)

3.6.4 Main Business Overview

3.7 Galderma

3.7.1 Company Basic Information, Manufacturing Base and Competitors

3.7.2 Dermatological Drugs Product Category, Application and Specification

3.7.3 Galderma Dermatological Drugs Sales, Revenue, Price and Gross Margin(2013-2018)

3.7.4 Main Business Overview

3.8 Amgen

3.8.1 Company Basic Information, Manufacturing Base and Competitors

3.8.2 Dermatological Drugs Product Category, Application and Specification

3.8.3 Amgen Dermatological Drugs Sales, Revenue, Price and Gross Margin(2013-2018)

3.8.4 Main Business Overview

3.9 AbbVie

3.9.1 Company Basic Information, Manufacturing Base and Competitors

3.9.2 Dermatological Drugs Product Category, Application and Specification

3.9.3 AbbVie Dermatological Drugs Sales, Revenue, Price and Gross Margin(2013-2018)

3.9.4 Main Business Overview

3.10 Merck

3.10.1 Company Basic Information, Manufacturing Base and Competitors

3.10.2 Dermatological Drugs Product Category, Application and Specification

3.10.3 Merck Dermatological Drugs Sales, Revenue, Price and Gross Margin(2013-2018)

3.10.4 Main Business Overview

4 Dermatological Drugs Market Status and Outlook by Regions

• 4.1 Global Market Status and Outlook by Regions
• 4.1.1 Global Dermatological Drugs Market Size and CAGR by Regions

4.1.2 North America

4.1.3 Asia-Pacific

4.1.4 Europe

4.1.5 South America

4.1.6 Middle East and Africa

4.2 Global Dermatological Drugs Sales and Revenue by Regions

4.2.1 Global Dermatological Drugs Sales and Market Share by Regions (2013-2018)

4.2.2 Global Dermatological Drugs Revenue and Market Share by Regions (2013-2018)

4.2.3 Global Dermatological Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

4.3 North America Dermatological Drugs Sales, Revenue, Price and Gross Margin

4.3.1 United States

4.3.2 Canada

4.3.3 Mexico

4.4 Europe Dermatological Drugs Sales, Revenue, Price and Gross Margin

4.4.1 Germany

4.4.2 UK

4.4.3 France

4.4.4 Italy

4.4.5 Russia

4.4.6 Turkey

4.5 Asia-Pacific Dermatological Drugs Sales, Revenue, Price and Gross Margin

4.5.1 China

4.5.2 Japan

4.5.3 Korea

4.5.4 Southeast Asia

4.5.4.1 Indonesia

4.5.4.2 Thailand

4.5.4.3 Malaysia

4.5.4.4 Philippines

4.5.4.5 Vietnam

4.5.5 India

4.5.6 Australia

4.6 South America Dermatological Drugs Sales, Revenue, Price and Gross Margin

4.6.1 Brazil

4.7 Middle East and Africa Dermatological Drugs Sales, Revenue, Price and Gross Margin

4.7.1 Egypt

4.7.2 GCC Countries

5 Dermatological Drugs Application/End Users

• 5.1 Dermatological Drugs Segment by Application
• 5.1.1 Acne

5.1.2 Skin Infections

5.1.3 Psoriasis

5.1.4 Dermatitis Drugs

5.1.5 Other

5.2 Global Dermatological Drugs Product Segment by Application

5.2.1 Global Dermatological Drugs Sales by Application

5.2.2 Global Dermatological Drugs Sales and Market Share by Application (2013-2018)

6 Global Dermatological Drugs Market Forecast

• 6.1 Global Dermatological Drugs Sales, Revenue Forecast (2018-2025)
• 6.1.1 Global Dermatological Drugs Sales and Growth Rate Forecast (2018-2025)

6.1.1 Global Dermatological Drugs Revenue and Growth Rate Forecast (2018-2025)

6.2 Global Dermatological Drugs Forecast by Regions

6.2.1 North America Dermatological Drugs Sales and Revenue Forecast (2018-2025)

6.2.2 Europe Dermatological Drugs Sales and Revenue Forecast (2018-2025)

6.2.3 Asia-Pacific Dermatological Drugs Sales and Revenue Forecast (2018-2025)

6.2.3.1 China

6.2.3.2 Japan

6.2.3.3 Korea

6.2.3.4 Southeast Asia

6.2.3.5 India

6.2.3.6 Australia

6.2.4 South America Dermatological Drugs Sales and Revenue Forecast (2018-2025)

6.2.5 Middle East and Africa Dermatological Drugs Sales and Revenue Forecast (2018-2025)

6.2.5.1 Egypt

6.2.5.2 GCC Countries

6.3 Dermatological Drugs Forecast by Type

6.3.1 Global Dermatological Drugs Sales and Revenue Forecast by Type (2018-2025)

6.3.2 Prescription-Based Drugs Gowth Forecast

6.3.3 Over-the-Counter Drugs Gowth Forecast

6.4 Dermatological Drugs Forecast by Application

6.4.1 Global Dermatological Drugs Sales Forecast by Application (2018-2025)

6.4.2 Global Dermatological Drugs Forecast in Acne

6.4.3 Global Dermatological Drugs Forecast in Skin Infections

7 Dermatological Drugs Upstream Raw Materials

• 7.1 Dermatological Drugs Key Raw Materials
• 7.1.1 Key Raw Materials

7.1.2 Key Raw Materials Price

7.1.3 Raw Materials Key Suppliers

7.2 Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Dermatological Drugs Industrial Chain Analysis

8 Marketing Strategy Analysis, Distributors

• 8.1 Marketing Channel
• 8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Distributors

8.3 Downstream Customers

9 Research Findings and Conclusion

Appendix

Methodology/Research Approach

Research Programs/Design

Market Size Estimation

Market Breakdown and Data Triangulation

Data Source

Secondary Sources

Primary Sources

Disclaimer

This report studies the Dermatological Drugs market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

 

Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various skin, nails, hair diseases, pigmentation, acne, wrinkles, psoriasis, and others.

Different techniques are used in dermatology such as topical & systemic medications, laser therapy, radio therapy, photodynamic therapy, vitiligo surgery, dermatological surgery, and others.

The global Dermatological Drugs market was xx million US$ in 2017 and is expected to xx million US$ by the end of 2025, growing at a CAGR of xx% between 2018 and 2025.

 

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Dermatological Drugs in these regions, from 2013 to 2025, covering

    North America (United States, Canada and Mexico)

    Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

    Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

    South America (Brazil etc.)

    Middle East and Africa (Egypt and GCC Countries)

 

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

    Bayer

    Johnson & Johnson

    Pfizer

    Novartis

    GlaxoSmithKline

    AstraZeneca

    Galderma

    Amgen

    AbbVie

    Merck

By the product type, the market is primarily split into

    Prescription-Based Drugs

    Over-the-Counter Drugs

By the end users/application, this report covers the following segments

    Acne

    Skin Infections

    Psoriasis

    Dermatitis Drugs

    Other

 

We can also provide the customized separate regional or country-level reports, for the following regions:

    North America

        United States

        Canada

        Mexico

    Asia-Pacific

        China

        India

        Japan

        South Korea

        Australia

        Indonesia

        Singapore

        Malaysia

        Philippines

        Thailand

        Vietnam

        Rest of Asia-Pacific

    Europe

        Germany

        France

        UK

        Italy

        Spain

        Russia

        Rest of Europe

    Central & South America

        Brazil

        Rest of Central & South America

    Middle East & Africa

        GCC Countries

        Turkey

        Egypt

        South Africa

        Rest of Middle East & Africa

 

The study objectives of this report are:

    To study and analyze the global Dermatological Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

    To understand the structure of Dermatological Drugs market by identifying its various subsegments.

    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

    Focuses on the key global Dermatological Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

    To analyze the Dermatological Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.

    To project the value and volume of Dermatological Drugs submarkets, with respect to key regions (along with their respective key countries).

    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

    To strategically profile the key players and comprehensively analyze their growth strategies.

 

In this study, the years considered to estimate the market size of Dermatological Drugs are as follows:

    History Year: 2013-2017

    Base Year: 2017

    Estimated Year: 2018

    Forecast Year 2018 to 2025

 

This report includes the estimation of market size for value (million USD) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dermatological Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

 

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

 

Key Stakeholders

Raw material suppliers

Distributors/traders/wholesalers/suppliers

Regulatory bodies, including government agencies and NGO

Commercial research & development (R&D) institutions

Importers and exporters

Government organizations, research organizations, and consulting firms

Trade associations and industry bodies

End-use industries

 

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Further breakdown of Dermatological Drugs market on basis of the key contributing countries.

Detailed analysis and profiling of additional market players.